Topics
High-grade gliomas | Treatment | Targeted therapy | Camrelizumab
Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy > Camrelizumab
Chen Z, Guo C, Yang Q, Lin F, Hu W, Xi S, Zhang J, Jiang X, Li D,
Chen Y, Ke C, Zhou J, Zhou Z, Ceng S.
AB048.
Evidence of effectiveness of neoadjuvant
camrelizumab and apatinib in patients
with recurrent high-grade gliomas.
Chin
Clin Oncol. 2024 Aug
30;13(Suppl 1):AB048. doi:
10.21037/cco-24-ab048. PMID:
39295366. Interventional study. ˍ